Analyst Ratings for Vanda Pharmaceuticals (VNDA)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/25/2022 | Jefferies | Chris Howerton | Downgrade | Hold (Buy) |
12.00 (24.00) |
13.07 (4.48) |
-65.72% | Details |
5/12/2021 | BofA Securities | N/A | New Coverage | Buy (N/A) |
22.00 (N/A) |
17.83 (4.48) |
-74.87% | Details |